X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet   (SUNP)

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 422.2
Mkt Cap Rs m 1,016,011
Vol '000 1,346.2
P/E X 34.4
P/CF X 24.6
EPS (TTM) Rs 12.3
% ch % -2.1
No. of shares m 2,406.75
% ch week % 0.5
% ch 1-mth % -24.8
% ch 12-mth % -18.3
52 week H/L Rs 678.8/391.1
(As on Dec 13, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs6531,0741,201842701 
Low Rs493570706572433 
Sales per share (Unadj.) Rs77.6132.3118.4131.6110.4 
Earnings per share (Unadj.) Rs15.221.923.532.711.0 
Diluted earnings per shareRs13.118.923.532.610.9 
Cash flow per share (Unadj.) Rs17.127.727.837.917.2 
Dividends per share (Unadj.) Rs1.503.001.003.502.00 
Adj. dividends per shareRs1.292.581.003.491.99 
Dividend yield (eoy) %0.30.40.10.50.4 
Book value per share (Unadj.) Rs89.4135.2137.1152.7158.8 
Adj. book value per shareRs77.0116.4137.0152.2158.3 
Shares outstanding (eoy) m2,071.162,071.162,406.602,399.262,399.26 
Bonus/Rights/Conversions  B1:1---- 
Price / Sales ratio x7.46.28.15.45.1 
Avg P/E ratio x37.837.540.621.751.6 
P/CF ratio (eoy) x33.429.734.318.632.9 
Price / Book Value ratio x6.46.17.04.63.6 
Dividend payout %9.913.74.310.718.2 
Avg Mkt Cap Rs m1,186,7751,703,0112,294,8131,696,8771,360,021 
No. of employees `00014.0NA14.717.517.8 
Total wages/salary Rs m20,74445,02647,72349,02353,671 
Avg. sales/employee Rs Th11,486.0NM19,317.218,028.314,890.9 
Avg. wages/employee Rs Th1,481.7NM3,236.12,798.83,017.1 
Avg. net profit/employee Rs Th2,243.9NM3,836.94,473.81,480.6 
SUN PHARMA INCOME DATA
Net Sales Rs m160,804273,920284,870315,784264,895 
Other income Rs m2,6475,4776,5836,2328,388 
Total revenues Rs m163,451279,397291,453322,016273,282 
Gross profit Rs m72,87378,66781,583100,89356,081 
Depreciation Rs m4,09211,94710,37512,64814,998 
Interest Rs m4425,7905,2323,9985,176 
Profit before tax Rs m70,98666,40772,55890,47944,295 
Minority Interest Rs m-7,375-9,363000 
Prior Period Items Rs m0-1261500 
Extraordinary Inc (Exp) Rs m-25,174-2,378-6,8520-9,505 
Tax Rs m7,0229,1479,13812,1168,452 
Profit after tax Rs m31,41545,39456,58378,36326,338 
Gross profit margin %45.328.728.631.921.2 
Effective tax rate %9.913.812.613.419.1 
Net profit margin %19.516.619.924.89.9 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m186,865288,782299,413329,537316,359 
Current liabilities Rs m59,896153,294131,440178,870198,643 
Net working cap to sales %79.049.559.047.744.4 
Current ratio x3.11.92.31.81.6 
Inventory Days Days7176827995 
Debtors Days Days50688783108 
Net fixed assets Rs m58,242151,694180,477204,766213,178 
Share capital Rs m2,0712,0712,4072,3992,399 
"Free" reserves Rs m163,019278,009327,418363,997378,606 
Net worth Rs m185,250280,080329,825366,397381,006 
Long term debt Rs m48713,59831,10314,36117,721 
Total assets Rs m293,708501,601555,303614,102643,028 
Interest coverage x161.612.514.923.69.6 
Debt to equity ratio x000.100 
Sales to assets ratio x0.50.50.50.50.4 
Return on assets %10.810.211.113.44.9 
Return on equity %17.016.217.221.46.9 
Return on capital %20.920.519.724.810.0 
Exports to sales %14.116.913.900 
Imports to sales %3.64.53.100 
Exports (fob) Rs m22,71346,23539,57200 
Imports (cif) Rs m5,77912,2298,88200 
Fx inflow Rs m23,16848,70642,17144,11840,816 
Fx outflow Rs m12,62925,56421,58324,48430,143 
Net fx Rs m10,53923,14220,58819,63410,673 
SUN PHARMA CASH FLOW
From Operations Rs m 39,592 56,157 66,859 70,822 39,072 
From Investments Rs m -23,668 -28,657 -43,716 -42,216 -33,708 
From Financial Activity Rs m 5,066 -11,865 -18,885 -22,854 -15,393 
Net Cashflow Rs m 20,990 15,635 8,482 6,107 -7,359 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.5

Read: SUN PHARMA 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare SUN PHARMA With:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 150 Points Higher; Banking Stocks Witness Buying(Closing)

Indian share markets continued their momentum and ended the day on a positive note. Gains were largely seen in the banking sector, consumer durables sector and realty sector.

Views on news

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Sep 19, 2018 | Updated on Sep 19, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1% (Quarterly Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

For the quarter ended June 2018, SUN PHARMA has posted a net profit of Rs 11 bn (up 446.1% YoY). Sales on the other hand came in at Rs 72 bn (up 16.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - MYLAN COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS